貨號
產(chǎn)品規格
售價(jià)
備注
BN41942R-50ul
50ul
￥1486.00
交叉反應：Mouse,Human(predicted:Rabbit,Horse,Pig,Dog,Rat) 推薦應用：WB,Flow-Cyt,ELISA
BN41942R-100ul
100ul
￥2360.00
交叉反應：Mouse,Human(predicted:Rabbit,Horse,Pig,Dog,Rat) 推薦應用：WB,Flow-Cyt,ELISA
BN41942R-200ul
200ul
￥3490.00
交叉反應：Mouse,Human(predicted:Rabbit,Horse,Pig,Dog,Rat) 推薦應用：WB,Flow-Cyt,ELISA
產(chǎn)品描述
| 英文名稱(chēng) | Tartrate Resistant Acid Phosphatase |
| 中文名稱(chēng) | 抗酒石酸酸性磷酸酶5型/5型酸性磷酸酶抗體 |
| 別 名 | Type 5 acid phosphatase; Acid phosphatase 5 tartrate resistant; ACP5; PPA5_HUMAN; T5ap; Tartrate resistant acid ATPase; Tartrate resistant acid phosphatase type 5; Tartrate resistant acid phosphatase type 5 precursor; Tartrate-resistant acid ATPase; Tartrate-resistant acid phosphatase type 5; TR AP; TR-AP; TrATPase; Type 5 acid phosphatase. |
| 研究領(lǐng)域 | 腫瘤 細胞生物 免疫學(xué) 信號轉導 |
| 抗體來(lái)源 | Rabbit |
| 克隆類(lèi)型 | Polyclonal |
| 交叉反應 | Human, Mouse, (predicted: Rat, Dog, Pig, Horse, Rabbit, ) |
| 產(chǎn)品應用 | WB=1:500-2000 ELISA=1:5000-10000 not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 分 子 量 | 34kDa |
| 細胞定位 | 細胞漿 |
| 性 狀 | Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human TRAP/Tartrate Resistant Acid Phosphatase:101-200/325 |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 儲 存 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| 保存條件 | Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. |
| PubMed | PubMed |
| 產(chǎn)品介紹 | Tartrate-resistant acid phosphatase is an iron containing glycoprotein that catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. TRAP is the most basic of the acid phosphatases and is the only form not inhibited by L+-tartrate. TRAP is a relatively minor lysosomal enzyme which may be activated in certain pathologies such as Hodgkin’s disease and B- and T-cell leukemias. Receptor activator of NFκB ligand (RANKL) plays an essential role in osteoclast differentiation and activation by increasing the expression of protease osteoclast markers such as TRAP. TRAP has collagenolytic activity and plays a major role in ligament degradation. Function: Involved in osteopontin/bone sialoprotein dephosphorylation. Its expression seems to increase in certain pathological states such as Gaucher and Hodgkin diseases, the hairy cell, the B-cell, and the T-cell leukemias. Subunit: Exists either as monomer or, after proteolytic processing, as a dimer of two chains linked by disulfide bond(s). Subcellular Location: Lysosome. DISEASE: Defects in ACP5 are the cause of spondyloenchondrodysplasia with immune dysregulation (SPENCDI) [MIM:607944]. A disease characterized by vertebral and metaphyseal dysplasia, spasticity with cerebral calcifications, and strong predisposition to autoimmune diseases. The skeletal dysplasia is characterized by radiolucent and irregular spondylar and metaphyseal lesions that represent islands of chondroid tissue within bone. Note=ACP5 inactivating mutations result in a functional excess of phosphorylated osteopontin causing deregulation of osteopontin signaling and consequential autoimmune disease. Similarity: elongs to the metallophosphoesterase superfamily. Purple acid phosphatase family. SWISS: P13686 Gene ID: 54 Database links: Entrez Gene: 54 Human Entrez Gene: 11433 Mouse Omim: 171640 Human SwissProt: P13686 Human SwissProt: Q05117 Mouse Unigene: 1211 Human Unigene: 46354 Mouse Unigene: 171928 Rat Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 抗酒石酸鹽酸性磷酸酶(Tartrate-Resistant Acid Phosphatase,TRAP)是破骨細胞功能的重要標志物,它的活性與破骨細胞活性呈正相關(guān). |
在線(xiàn)咨詢(xún)
English
